Cargando…
Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme
The biology of recurrent glioblastoma multiforme (GBM) is a dynamic process influenced by selection pressure induced by different antitumoural therapies. The poor clinical outcome of tumours in the recurrent stage necessitates the development of effective therapeutic strategies. Checkpoint-inhibitio...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650331/ https://www.ncbi.nlm.nih.gov/pubmed/29088776 http://dx.doi.org/10.18632/oncotarget.18819 |